产NDM-14肺炎克雷伯菌ST147克隆在西班牙加那利群岛的跨境出现与暴发
研究分析2023年西班牙加那利群岛 recovered 的30株产NDM-14肺炎克雷伯菌ST147克隆分离株,通过全基因组测序和药敏试验确认局部暴发,并显示该克隆与国际菌株高度相关,提示跨境传播;氨曲南/阿维巴坦体外活性最强(MICs <0.125 mg/L)。
要点
- 产NDM-14肺炎克雷伯菌ST147克隆在加那利群岛形成局部暴发,需密切监测。
- 该克隆与国际菌株高度相关,支持跨境传播。
- 氨曲南/阿维巴坦体外活性最强(MICs <0.125 mg/L)。
核心结论
- 产NDM-14肺炎克雷伯菌ST147克隆在西班牙加那利群岛出现并快速传播,构成局部暴发,且与国际菌株相关,提示跨境扩散。
研究设计与样本
- 对2023年 recovered 的30株分离株进行临床与流行病学数据回顾、全基因组测序(评估克隆相关性和耐药组)及参考肉汤微量稀释法药敏试验。
主要发现
- 30株分离株形成基因组距离极小且耐药组相同的明确聚类,确认局部暴发。
- 这些克隆与其他国际产NDM-14肺炎克雷伯菌ST147分离株高度相关。
- 氨曲南/阿维巴坦是最活跃的治疗选择(MICs <0.125 mg/L)。
关键数值与推荐
- 氨曲南/阿维巴坦对产NDM-14肺炎克雷伯菌ST147克隆的MICs <0.125 mg/L。
临床怎么用
- 对产NDM-14肺炎克雷伯菌ST147克隆需密切监测以预防进一步传播。
- 氨曲南/阿维巴坦可作为体外活性最强的治疗选项参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The emergence of a high-risk New Delhi metallo-β-lactamase 14-producing Klebsiella pneumoniae sequence type 147 clone is of public health concern because of its rapid international spread. We report cross-border emergence and rapid dissemination of that clone in the Canary Islands, Spain, during 2023-2025. We analyzed 30 isolates recovered during 2023 in detail by reviewing clinical and epidemiologic data, conducting whole-genome sequencing to assess clonal relatedness and analyze resistomes, and performing antimicrobial susceptibility testing of novel therapeutic options through reference broth microdilution. The isolates formed a well-defined cluster, with minimal genomic distance and identical resistomes, confirming the local outbreak. Those clones were also closely related to other international New Delhi metallo-β-lactamase 14-producing K. pneumoniae sequence type 147 isolates, supporting the ongoing cross-border expansion of that clone. Aztreonam/avibactam was the most active therapeutic option (MICs <0.125 mg/L). Our findings highlight the need for close monitoring to prevent further dissemination of this clone.
引用
- Aja-Macaya P, Blanco-Martín T, Mateo-León C, et al. Emergence of New Delhi Metallo-β-Lactamase 14-Producing Klebsiella pneumoniae Sequence Type 147 Clone in Spain and Outbreak in the Canary Islands. Emerg Infect Dis. 2026. PMID: 41612546. doi:10.3201/eid3201.251504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。